Eurazeo invests in Imapôle in European market’s third healthcare deal in a week

The Nov Santé Actions Non Cotées fund has completed a more than €50 million investment in the company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this